2 new genetic mutations identified as cause of severe aHUS in humans, 24 |…
Two new mutations in the FHR2 were first identified as the cause of severe atypical hemolytic uremic syndrome (aHUS) in a 24-year-old patient. After two years of dialysis, the man underwent a kidney transplant which was preceded by preventive treatment with Soliris (eculizumab) and plasma exchange therapy. Soliris was discontinued two months after surgery, and …
2 new genetic mutations identified as cause of severe aHUS in humans, 24 |… Read More »
